Acceptability of a Sublingual Drug Formulation for Respiratory Tract Infections in Children Aged 3 to 5 Years

• Váldodahkkit: Andrzej Emeryk (Dahkki), Thibault Vallet (Dahkki), Ewelina Wawryk-Gawda (Dahkki), Arkadiusz Jędrzejewski (Dahkki), Frederic Durmont (Dahkki), Fabrice Ruiz (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: MDPI AG, 2021-02-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

In pediatrics, acceptability has emerged as a key factor for compliance, and consequently for treatment safety and efficacy. Polyvalent mechanical bacterial lysate (PMBL) in 50-mg sublingual tablets is indicated in children and adults for the prophylaxis of recurrent respiratory tract infections. Th...